Treatment of pleural malignancies by photo-induction combined to systemic chemotherapy: Proof of concept on rodent lung tumors and feasibility study on porcine chest cavities

Lasers in Surgery and Medicine

Volumn 47, Issue 10, 2015, Pages 807-816

  Wang, Xingyu ^a   Gronchi, Fabrizio ^a   Bensimon, Michael ^b   Mercier, Thomas ^a   Decosterd, Laurent Arthur ^a   Wagnières, Georges ^b   Debefve, Elodie ^a   Ris, Hans Beat ^a   Letovanec, Igor ^c   Peters, Solange ^a   Perentes, Jean Yannis ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b EPFL   (Switzerland)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

adenocarcinoma; chemotherapy; lipoplatin; lung; mesothelioma; minipig; photodynamic therapy; rodent; sarcoma; visudyne

Indexed keywords

CISPLATIN; VERTEPORFIN; ANTINEOPLASTIC AGENT; PHOTOSENSITIZING AGENT; PORPHYRIN;

ADENOCARCINOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG TISSUE LEVEL; DRUG TUMOR LEVEL; DRUG UPTAKE; FEASIBILITY STUDY; LASER; LUNG TUMOR; MALE; MASS SPECTROMETRY; MESOTHELIOMA; MINIPIG; NONHUMAN; PHOTODYNAMIC THERAPY; PLEURA BIOPSY; PORCINE MODEL; PRIORITY JOURNAL; RAT; SARCOMA; VIDEO ASSISTED THORACOSCOPIC SURGERY; ANIMAL; CANCER TRANSPLANTATION; DRUG ADMINISTRATION; FISCHER 344 RAT; LUNG NEOPLASMS; PHOTOCHEMOTHERAPY; PIG; PROCEDURES; TREATMENT OUTCOME; TUMOR CELL LINE;

ADENOCARCINOMA; ANIMALS; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL LINE, TUMOR; CISPLATIN; DRUG ADMINISTRATION SCHEDULE; FEASIBILITY STUDIES; LUNG NEOPLASMS; MALE; MESOTHELIOMA; NEOPLASM TRANSPLANTATION; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; RATS; RATS, INBRED F344; SARCOMA; SWINE; TREATMENT OUTCOME;

EID: 84955744327     PISSN: 01968092     EISSN: 10969101     Source Type: Journal    
DOI: 10.1002/lsm.22422     Document Type: Article

References (31)

1. Statement of the american thoracic society: Management of malignant pleural effusions. Am J Respir Crit Care Med 2000; 162: 1987-2001.
2. Snyder JW, Greco WR, Bellnier DA, Vaughan L, Henderson BW,. Photodynamic therapy: A means to enhanced drug delivery to tumors. Cancer Res 2003; 63: 8126-8131.
3. Cheng C, Debefve E, Haouala A, Andrejevic-Blant S, Krueger T, Ballini JP, et al., Photodynamic therapy selectively enhances liposomal doxorubicin uptake in sarcoma tumors to rodent lungs. Lasers Surg Med 2010; 42: 391-399.
4. Wang Y, Gonzalez M, Cheng C, Haouala A, Krueger T, Peters S, et al., Photodynamic induced uptake of liposomal doxorubicin to rat lung tumors parallels tumor vascular density. Lasers Surg Med 2012; 44: 318-324.
5. Perentes JY, Wang Y, Wang X, Abdelnour E, Gonzalez M, Decosterd L, Wagnieres G, van den Bergh H, Peters S, Ris HB, Krueger T,. Low-dose vascular photodynamic therapy decreases tumour interstitial fluid pressure, which promotes liposomal doxorubicin distribution in a murine sarcoma metastasis model. Transl Oncol 2014; 7: 393-399.
6. Wang Y, Wang X, Le Bitoux MA, Wagnieres G, Vandenbergh H, Gonzalez M, Ris HB, Perentes JY, Krueger T,. Fluence plays a critical role on the subsequent distribution of chemotherapy and tumor growth delay in murine mesothelioma xenografts pre-treated by photodynamic therapy. Lasers Surg Med 2015; 47: 323-330.
7. Boulikas T,. Clinical overview on Lipoplatin: A successful liposomal formulation of cisplatin. Expert Opin Investig Drugs 2009; 18: 1197-1218.
8. Stathopoulos GP, Boulikas T, Vougiouka M, Deliconstantinos G, Rigatos S, Darli E, Viliotou V, Stathopoulos JG,. Pharmacokinetics and adverse reactions of a new liposomal cisplatin (Lipoplatin): Phase I study. Oncol Rep 2005; 13: 589-595.
9. Stathopoulos GP, Antoniou D, Dimitroulis J, Stathopoulos J, Marosis K, Michalopoulou P,. Comparison of liposomal cisplatin versus cisplatin in non-squamous cell non-small-cell lung cancer. Cancer Chemother Pharmacol 2011; 68: 945-950.
10. Krueger T, Altermatt HJ, Mettler D, Scholl B, Magnusson L, Ris HB,. Experimental photodynamic therapy for malignant pleural mesothelioma with pegylated mTHPC. Lasers Surg Med 2003; 32: 61-68.
11. Krueger T, Pan Y, Tran N, Altermatt HJ, Opitz I, Ris HB,. Intraoperative photodynamic therapy of the chest cavity in malignant pleural mesothelioma bearing rats. Lasers Surg Med 2005; 37: 271-277.
12. Henderson BW, Gollnick SO., Mechanistic principles of photodynamic therapy. In:, Vo-Dinh T, (ed), Biomedical Photonics Handbook, Boca Raton: CRC Press, 2003. pp 36-1-36-27.
13. Ris HB, Altermatt HJ, Inderbitzi R, Hess R, Nachbur B, Stewart JC, Wang Q, Lim CK, Bonnett R, Berenbaum MC,. Photodynamic therapy with chlorins for diffuse malignant mesothelioma: Initial clinical results. Br J Cancer 1991; 64: 1116-1120.
14. Ris HB, Altermatt HJ, Nachbur B, Stewart CM, Wang Q, Lim CK, Bonnett R, Althaus U,. Intraoperative photodynamic therapy with m-tetrahydroxyphenylchlorin for chest malignancies. Lasers Surg Med 1996; 18: 39-45.
15. Takita H, Mang TS, Loewen GM, Antkowiak JG, Raghavan D, Grajek JR, Dougherty TJ,. Operation and intracavitary photodynamic therapy for malignant pleural mesothelioma: a phase II study. Ann Thorac Surg 1994; 58: 995-998.
16. Baas P, Murrer L, Zoetmulder FA, Stewart FA, Ris HB, van Zandwijk N, Peterse JL, Rutgers EJ,. Photodynamic therapy as adjuvant therapy in surgically treated pleural malignancies. Br J Cancer 1997; 76: 819-826.
17. Pass HI, Temeck BK, Kranda K, Thomas G, Russo A, Smith P, Friauf W, Steinberg SM,. Phase III randomized trial of surgery with or without intraoperative photodynamic therapy and postoperative immunochemotherapy for malignant pleural mesothelioma. Ann Surg Oncol 1997; 4: 628-633.
18. Moskal TL, Dougherty TJ, Urschel JD, Antkowiak JG, Regal AM, Driscoll DL, Takita H,. Operation and photodynamic therapy for pleural mesothelioma: 6-year follow-up. Ann Thorac Surg 1998; 66: 1128-1133.
19. Friedberg JS, Mick R, Stevenson J, Metz J, Zhu T, Buyske J, Sterman DH, Pass HI, Glatstein E, Hahn SM,. A phase I study of Foscan-mediated photodynamic therapy and surgery in patients with mesothelioma. Ann Thorac Surg 2003; 75: 952-959.
20. Friedberg JS, Culligan MJ, Mick R, Stevenson J, Hahn SM, Sterman D, Punekar S, Glatstein E, Cengel K,. Radical pleurectomy and intraoperative photodynamic therapy for malignant pleural mesothelioma. Ann Thorac Surg 2012; 93: 1658-1665.
21. Pelton J, Kowalyshyn M, Keller S,. Intrathoracic organ injury associated with photodynamic therapy. J Thorac Cardiovasc Surg 1992; 103: 1218-1223.
22. Fingar VH,. Vascular effects of photodynamic therapy. J Clin Laser Med Surg 1996; 14: 323-328.
23. Debefve E, Pegaz B, Ballini JP, Konan YN, Van den Bergh H,. Combination therapy using aspirin enhanced photodynamic selective drug delivery. Vasc Pharmacol 2007; 46: 171-180.
24. Debefve E, Pegaz B, van den Bergh H, Wagnières G, Lange N, Ballini JP,. Video monitoring of neovessel occlusion induced by photodynamic therapy with verteporfin (Visudyne), in the CAM model. Angiogenesis 2008; 11: 235-243.
25. Debefve E, Cheng C, Schaefer S, Yan H, Ballini JP, Van den Bergh H, lehr HA, Ruffiezx C, Ris HB, Krueger T,. Visudyne-mediated photodynamic therapy enhances macromolecular delivery in normal tissue: Insights using intravital microscopy. J Photochem Photobiol B 2009; 98: 69-76.
26. Debefve E, Mithieux F, Perentes JY, Wang Y, Cheng C, Schaefer SC, Ruffieux C, Ballini JP, Gonzalez M, van den Bergh H, Ris HB, Lehr HA, Krueger T,. Leukocyte-endothelial cell interaction is necessary for photodynamic therapy induced vascular permeabilization. Lasers Surg Med 2011; 43: 696-704.
27. Bessler N, Committee VSW,. Verteporfin therapy in age-related macular degeneration: An open-label multicenter photodynamic study of 4435 patients. Retina 2004; 20: 3-7.
28. Jain RK,. Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy. Science 2005; 307: 58-62.
29. Sandell J, Zhu TC,. A review of in-vivo optical properties of human tissues and its impact on PDT. J Biophotonics 2011; 4 (11-12): 773-787.
30. Porcelli R, Viau A, Demeny M, Naftchi NE, Bergofsky EH,. Relation between hypoxic pulmonary vasoconstriction, its humoral mediators and alpha-beta adrenergic receptors. Chest 1977; 71 (2 suppl): 249-251.
31. Krueger T, Kuemmerle A, Kosinski M, Denys A, Magnusson L, Stupp R, Delaloye AB, Klepetko W, Decosterd L, Ris HB, Dusmet M,. Cytostatic lung perfusion results in heterogeneous spatial regional blood flow and drug distribution: Evaluation of different cytostatic lung perfusion techniques in a porcine model. J Thorac Cardiovasc Surg 2006; 132 (2): 304-311.